NCT00030667 2015-04-15Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodNational Cancer Institute (NCI)Phase 2 Completed100 enrolled
NCT00093821 2013-06-04Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsNational Cancer Institute (NCI)Phase 1 Completed70 enrolled